Allosteric modulators for
human health
About us
Overview
Addex Corporate Presentation
Our people
Executive Officers
Non-Executive Directors
Scientific Advisory Board
Contact
Privacy Policy
Careers
Pipeline
Research And Development
mGlu2 NAM Developing a Novel Approach to Fight Mild Neurocognitive Disorders and Depression
Clinical and Pre-Clinical Pipeline
Technology platform
Allosteric modulation
Our capabilities
Screening Assays
Chemistry
Publications
Partners & collaboration
Investors
Stock Data
Addex Corporate Presentation
Press releases
Ad hoc announcements (Art. 53 L.R)
Events
Financial Reports
Analyst Reports
General Meetings
SEC / SIX Filings
Guide to US ADSS for Six Shareholders
Register for email news
Corporate Governance
Contact
Media
Press releases
Contact
Executive Officers
Executive management
Tim Dyer
Co-Founder, Board Director and Chief Executive Officer
Roger Mills
Board Director and Chief Medical Officer
Robert Lütjens
Head of Discovery – Biology
Jean-Philippe Rocher
Head of Discovery - Chemistry
Mikhail Kalinichev
Head of Translational Science
